The GM focused on inhaled & nasal drugs

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gemma Budd, General Manager at Nanopharm.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gemma, covering:

• Why being in an overly strategic, future-focused role led her to make the tough decision to move on
• Identifying the joy of solving problems for customers in service-based businesses
• Why her holistic experience led to the GM role...and the reality in becoming the leader
• The factors driving growth for inhalation delivery for nasal and pulmonary routes
• Being a niche player in a global market - why clients don't care where you are when you know what you're doing

With a background in biomedical science, Gemma has built her career over the past 15 years by leveraging and expanding that knowledge in the pharmaceutical and medical devices industry. She has worked in companies providing analytical and formulation development services, materials science consultancy and manufacturing of drug delivery systems – primarily in commercial and technical roles. 

She is currently the General Manager of Nanopharm, a specialist CRO focusing on developing nasally administered and inhaled drug products for pharmaceutical companies worldwide, through her team of 75 employees in the UK. She is focused on ensuring the business continually delivers, innovates and evolves in their niche space to ensure their clients benefit from their expertise that is not widely available in the industry, developing both exceptional talent and unique technology platforms, and ensuring they combine to deliver high quality services to help get drugs to patients quickly, safely and effectively.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! 

Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.